Pretransplant interferon-γ secretion by CMV-specific CD8+ T cells informs the risk of CMV replication after transplantation

American Journal of Transplantation

Volumn 13, Issue 3, 2013, Pages 738-745

  Cantisan S ^a   Lara, R ^a   Montejo, M ^b   Redel, J ^a   Rodriguez Benot A ^a   Gutierrez Aroca J ^a   Gonzalez Padilla M ^a   Bueno, L ^b   Rivero, A ^a   Solana, R ^a   Torre Cisneros, J ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b HOSPITAL DE CRUCES   (Spain)

Author keywords

CD8+ T cells; Cytomegalovirus replication; interferon ; solid organ transplantation

Indexed keywords

GAMMA INTERFERON;

ADULT; AGED; ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOMEGALOVIRUS; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNOREACTIVITY; INFECTION RISK; KIDNEY TRANSPLANTATION; LUNG TRANSPLANTATION; MALE; ORGAN TRANSPLANTATION; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SERODIAGNOSIS; VIRUS REPLICATION;

ADULT; AGED; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GRAFT REJECTION; HUMANS; INTERFERON-GAMMA; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; YOUNG ADULT;

EID: 84874446978     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12049     Document Type: Article

References (25)

1. Torre-Cisneros J, Farinas MC, Caston JJ, et al. GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients. Enferm Infecc Microbiol Clin 2011; 29: 735-758.
2. Kotton CN, Kumar D, Caliendo AM, et al. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 2010; 89: 779-795.
3. San Juan R, Aguado JM, Lumbreras C, et al. Impact of current transplantation management on the development of cytomegalovirus disease after renal transplantation. Clin Infect Dis 2008; 47: 875-882.
4. Westall GP, Mifsud NA, Kotsimbos T,. Linking CMV serostatus to episodes of CMV reactivation following lung transplantation by measuring CMV-specific CD8+ T-cell immunity. Am J Transplant 2008; 8: 1749-1754.
5. Atabani SF, Smith C, Atkinson C, et al. Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy. Am J Transplant 2012; 12: 2457-2464.
6. Emery VC, Asher K, Sanjuan Cde J,. Importance of the cytomegalovirus seropositive recipient as a contributor to disease burden after solid organ transplantation. J Clin Virol 2012; 54: 125-129.
7. Harari A, Zimmerli SC, Pantaleo G,. Cytomegalovirus (CMV)-specific cellular immune responses. Hum Immunol 2004; 65: 500-506.
8. Moss P, Khan N,. CD8(+) T-cell immunity to cytomegalovirus. Hum Immunol 2004; 65: 456-464.
9. Benmarzouk-Hidalgo OJ, Cisneros JM, Cordero E, et al. Therapeutic effect of the acquisition of cytomegalovirus-specific immune response during preemptive treatment. Transplantation 2011; 91: 927-933.
10. Crough T, Fazou C, Weiss J, et al. Symptomatic and asymptomatic viral recrudescence in solid-organ transplant recipients and its relationship with the antigen-specific CD8(+) T-cell response. J Virol 2007; 81: 11538-11542.
11. Mattes FM, Vargas A, Kopycinski J, et al. Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation. Am J Transplant 2008; 8: 990-999.
12. Giulieri S, Manuel O,. QuantiFERON(R)-CMV assay for the assessment of cytomegalovirus cell-mediated immunity. Expert Rev Mol Diagn 2011; 11: 17-25.
13. Lisowska KA, Debska-Slizien A, Jasiulewicz A, Heleniak Z, Bryl E, Witkowski JM,. Hemodialysis affects phenotype and proliferation of CD4-positive T lymphocytes. J Clin Immunol 2012; 32: 189-200.
14. Almanzar G, Schwaiger S, Jenewein B, et al. Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J Virol 2005; 79: 3675-3683.
15. Appay V, Dunbar PR, Callan M, et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002; 8: 379-385.
16. Cantisan S, Torre-Cisneros J, Lara R, et al. Age-dependent association between low frequency of CD27/CD28 expression on pp65 CD8+ T cells and cytomegalovirus replication after transplantation. Clin Vaccine Immunol 2009; 16: 1429-1438.
17. Derhovanessian E, Maier AB, Hahnel K, et al. Infection with cytomegalovirus but not herpes simplex virus induces the accumulation of late-differentiated CD4+ and CD8+ T-cells in humans. J Gen Virol 2011; 92: 2746-2756.
18. Tomiyama H, Takata H, Matsuda T, Takiguchi M,. Phenotypic classification of human CD8+ T cells reflecting their function: Inverse correlation between quantitative expression of CD27 and cytotoxic effector function. Eur J Immunol 2004; 34: 999-1010.
19. Weng NP, Akbar AN, Goronzy J,. CD28(-) T cells: their role in the age-associated decline of immune function. Trends Immunol 2009; 30: 306-312.
20. Nebbia G, Mattes FM, Smith C, et al. Polyfunctional cytomegalovirus- specific CD4+ and pp65 CD8+ T cells protect against high-level replication after liver transplantation. Am J Transplant 2008; 8: 2590-2599.
21. Kumar D, Chernenko S, Moussa G, et al. Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients. Am J Transplant 2009; 9: 1214-1222.
22. Boudreault AA, Xie H, Rakita RM, et al. Risk factors for late-onset cytomegalovirus disease in donor seropositive/recipient seronegative kidney transplant recipients who receive antiviral prophylaxis. Transpl Infect Dis 2011; 13: 244-249.
23. Luan FL, Samaniego M, Kommareddi M, Park JM, Ojo AO,. Choice of induction regimens on the risk of cytomegalovirus infection in donor-positive and recipient-negative kidney transplant recipients. Transpl Infect Dis 2010; 12: 473-479.
24. Lisboa LF, Kumar D, Wilson LE, Humar A,. Clinical utility of cytomegalovirus cell-mediated immunity in transplant recipients with cytomegalovirus viremia. Transplantation 2012; 93: 195-200.
25. Torre-Cisneros J,. Toward the individualization of cytomegalovirus control after solid-organ transplantation: The importance of the "individual pathogenic balance ". Clin Infect Dis 2009; 49: 1167-1168.